期刊文献+

下调P55PIK基因表达对乳腺癌MDA-MB-231细胞体外增殖和迁移能力的影响 被引量:2

Effect of siRNA-mediated P55PIK Downregulation on Proliferation and Migration of MDA-MB-231 Cells in vitro
下载PDF
导出
摘要 目的通过RNA干扰(RNA interference,RNAi)抑制P55PIK基因表达,观察下调P55PIK对人乳腺癌细胞株MDA-MB-231体外增殖和迁移能力的影响。方法利用脂质体将特异性针对P55PIK的siRNA瞬时转染P55PIK高表达细胞株MDA-MB-231,以转染无关序列siRNA(siRNA-NC)和未转染细胞作为对照。通过Western blot检测其对P55PIK表达的下调效果,MTT法和Transwell实验分别检测MDA-MB-231细胞的增殖和迁移能力。结果 siRNA-P55PIK明显下调MDA-MB-231细胞中P55PIK蛋白的表达;MTT检测显示下调P55PIK后,MDA-MB-231生长明显受到抑制;Transwell实验显示siRNA-P55PIK组穿膜细胞数为(5.2±1.3),显著低于siRNA-NC组(18.6±3.8)和空白对照组(18.4±4.3)(P<0.05)。结论应用RNAi抑制P55PIK基因的表达可抑制MDA-MB-231细胞体外增殖和迁移能力,为乳腺癌的靶向治疗提供了新思路。 Objective To explore the effect of siRNA-mediated downregulation of P55PIK on proliferation and migration of breast cancer cells in vitro.Methods Western blot was used to detect the expression of P55PIK in 3 breast cancer cell lines(MDA-MB-231,MCF-7,and T47D).P55PIK-targeted siRNA was transfected into MDA-MB-231 cells(high expression of P55PIK) through lipofectamine and downregulation of the targeted P55PIK was assessed by Western blot.MTT assay was used to estimate proliferation of cells.The ability of cell migration was assessed by using Transwell chamber migration models.Results P55PIK expression was obviously inhibited after siRNA-P55PIK transfection.After transfection,the proliferation of MDA-MB-231 cells was significantly inhibited compared to the blank and negative control groups(P0.05).The number of migratory cells in siRNA-NC negative control group,blank group and siRNA-P55PIK transfection group was(18.6±3.8),(18.4±4.3) and(5.2±1.3) respectively.Downregulation of P55PIK significantly reduced migration of MDA-MB-231 cells.Conclusion Downregulation of P55PIK expression could inhibit the in vitro proliferation and migration of human breast cancer cell line MDA-MB-231.This study provided preliminary results in the searching of targeted therapy for breast cancer.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2012年第6期643-646,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No.30973496,No.81172512) 国家重点基础研究发展计划(973计划)资助项目(No.973-2009CB521802)
关键词 乳腺癌 P55PIK RNA干扰 增殖 迁移 breast cancer P55PIK RNA interference proliferation migration
  • 相关文献

参考文献14

  • 1Katso R, Okkenhaug K, Ahmadi K, et al. Cellular function of phosphoinositide 3-kinases: implications for development,ho meostasis,and cancer[J]. Annu Rev Cell Dev Biol, 2001,17 615-675.
  • 2Willems L, Tamburini J, Chapuis N, et al. PI3K and roTOR si gnaling pathways in cancer z new data on targeted therapies [J]. Curr Oncol Rep, 2012,14(2) : 129-138.
  • 3Dituri F, Mazzocca A, Giannelli G, et al. PI3K functions in c- ancer progression, anticancer immunity and immune evasion by tumors[J]. Clin Dev Immunol,2011,2011:947858.
  • 4Vivanco I, Sawyers C L. The phosphatidylinositol 3-kinase A KT pathway in human caneer[J]. Nat Rev Cancer, 2002,2 (7) :489-501.
  • 5Pons S, Asano T, Glasheen E, et al. The structure and func tion of p55PIK reveal a new regulatory subunit for phosphati- dylinositol 3-kinase[J]. Mol Cell Biol, 1995, 15 (8): 4453 4465.
  • 6Zhang L, Huang J, Yang N, et al. Integrative genomic analysis of phosphatidylinositol 3'-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer[J]. Clin Cancer Res,2007,13(18 Pt 1):5314-5321.
  • 7Adams J R,Sehachter N F, Liu J C, et al. Elevated PI3K sig- naling drives multiple breast cancer subtypes[J]. Oncotarget, 2011,2(6) =435-447.
  • 8Soroceanu L, Kharbanda S, Chen R, et al. Identification of I- GF 2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth promoting axis in glioblastoma[J]. Proc Natl Acad Sci USA,2007,104(9) =3466-3471.
  • 9Zhou J,Chen G B,Tang Y C, et al. Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library[J]. BMC Med Genomics,2012,5(1) :34.
  • 10Xia X,Cheng A,Akinmade D,et al. The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinosit- ide 3-kinase binds Rb and induces cell cycle arrest[J] Mol Cell Biol, 2003,23(5) : 1717-1725.

二级参考文献42

  • 1高霞,龙浩成,刘双又,罗学来,李小兰,陶德定,胡俊波,龚建平.信号传导途径p55PI3K-Rb在胃肠道肿瘤中的表达及意义[J].华中科技大学学报(医学版),2006,35(6):761-763. 被引量:9
  • 2刘双又,王晶,高霞,罗学来,谢大兴,冯永东,陶德定,胡俊波,龚建平.磷脂酰肌醇-3激酶上的一段多肽对Jurkat细胞的周期阻滞作用[J].中华血液学杂志,2005,26(12):758-759. 被引量:6
  • 3王晶,刘双又,高霞,罗学来,夏献民,陶德定,龚建平,胡俊波.N24p55γPI3K靶向抑制胃癌细胞增殖的研究[J].中华实验外科杂志,2006,23(10):1221-1223. 被引量:13
  • 4KAELIN W J.Functions of the retinoblastoma protein[J].Bioessays,1999,21(11):950-958.
  • 5VANHAESEBROECK B,LEEVERS S J,PANAYOTOM G,et al.Phosphoinositide 3-kinases:a conserved family of signal transducers[J].Trends Biochem Sci,1997,22 (7):267-272.
  • 6XIA X,CHENG A,AKINMADE D,et al.The N-terminal 24 amino acids of the p55 gamma regulluatory subunit of phosphoinositide 3-kinase hinds Rb and induces cell cycle arrest[J].Mol Cell Biol,2003,23(5):1717-1725.
  • 7HU J B,LIU S,WANG J,et al.Overexpression of the Nterminal end of the 055γ regulatory subunit of phosphatidylinositol 3-kinase blocks cell cycle progression in gastric carcinoma cells[J].Int J Oncol,2005,26(5):1321-1327.
  • 8LUO J,MANNING B D,CANTLEY L C.Targeting the PI3K-Akt pathway in human cancer:rationale and promise[J].Cancer Cell,2003,4(4):257-262.
  • 9WARD S G,FINAN P.Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents[J].Curr Opin Pharmacol,2003,3 (4):426-434.
  • 10FAN Q W,WEISS W A.Isoform specific inhibitors of PI3 kinase in glioma[J].Cell Cycle,2006,5 (20):2301-2305.

共引文献10

同被引文献32

  • 1Wang G,Deng Y,Cao X, et al. Blocking p55PIK signaling in- hibits proliferation and induces differentiation of leukemia cells[J]. Cell Death Differ,2012,11(19) :1870-1879.
  • 2Pons S, Asano T, Glasheen E, et al. The structure and func- tion of p55PIK reveal a new regulatory subunit for phosphati- dylinositol 3-kinase[J]. Mol Cell Biol, 1995, 15 (8): 4453- 4465.
  • 3Hu J, Liu S,Wang J, et al. Overexpression of the N-terminal end of the p55 gamma regulatory subunit of phosphatidylinos- itol 3-kinase blocks cell cycle progression in gastric carcinoma cells[J]. Int J 0ncol,2005,26(5) :1321-1327.
  • 4Wang G,Chen C, Yang R, et al. p55PIK-PI3K stimulates an- giogenesis in colorectal cancer cell by activating NF-.B path- way[J]. Angiogenesis, 2013,16 (3) : 561-573.
  • 5Xia X,Cheng A,Akinmade D,et al. The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinosit- ide 3-kinase binds Rb and induces cell cycle arrest[J]. Mol Cell Biol,2003,23(5) :1717-1725.
  • 6Wang G,Cao X,Lai S,et al. PI3K stimulates DNA synthesis and cell-cycle progression via its p55PIK regulatory subunit interaction with PCNAE-J]. Mol Cancer Ther, 2013,12 (10) : 2100-2109.
  • 7Hermeking H. MicroRNAs in the p53 network:micromanage- ment of tumour suppress/on[J]. Nat Rev Cancer, 2012, 12 (9) :613-626.
  • 8Term6n S, Tan E, Heldin C, et al. p53 regulates epithelial mesenchymal transition induced by transforming growth fac- tor [J]. J Cell Physiol,2013,228(4):801-813.
  • 9He L, He X,Lim L P,et al. A microRNA component of the p53 tumour suppressor network [J]. Nature, 2007, 447 (7148) : 1130-1134.
  • 10Jemal A, Bray F, Center M M, et al. Global cancer statistics [J]. CA Cancer J C1in,2011,61(2) .69-90.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部